Ocular Therapeutix Completes US Pivotal Clinical Trial Enrollment for ReSure Sealant

Ocular Therapeutix, Inc., announced it has completed enrollment for its ReSure Sealant Pivotal Clinical Trial, designed to gain premarket approval by the FDA. The trial enrolled 488 patients at 24 sites throughout the United States. ReSure Sealant is a polyethylene glycol-based hydrogel, which is applied as a liquid...

Full Story →